Abstract Background Several clinical pharmacy activities are common to UK hospitals. It is not clear whether these are provided at similar levels, and whether they take similar amounts of time to carry out. Objective To quantify and compare clinical pharmacist ward activities between different UK hospitals. Setting Seven acute hospitals in the Greater London area (UK). Methods A list of common ward activities was developed. On five consecutive days, pharmacists visiting hospital wards documented total time spent and how many of each activity they undertook. Results were analysed by hospital. The range and number of activities per 100 occupied bed days, and per 24 beds were compared. Main outcome measure Time spent on wards and numbers of each activity undertaken. Results Pharmacists logged a total of 2291 h carrying out 40,000 activities. 4250 changes to prescriptions were made or recommended. 5901 individual medication orders were annotated for clarity or safety. For every 24 beds visited, mean time spent was 230 min-seeing 6.2 new patients, carrying out 3.9 calculations and 1.3 patient consultations, checking and authorising 1.8 discharge prescriptions, and providing staff with information twice. Other activities varied significantly, not all could be explained by differences in hospital specialties or Information Technology systems. Conclusion This is the first detailed comparison of clinical pharmacy ward activities between different hospitals. There are some typical levels of activities carried out. Wide variations in other activities could not always be explained. Despite a large number of contacts, pharmacists reported very few consultation sessions with patients.
Introduction
The role of pharmacists working on hospital wards has evolved over time, from focusing on medication supply to an increased emphasis on medicines reconciliation and medicines optimisation for patients to ensure the safe use of medication [1, 2] . Prescribing of medication remains the most common therapeutic intervention in healthcare, with the EQUIP study [3] showing a prescribing error rate of 8.9 % for inpatients, with pharmacists being pivotal as a safety net in identifying prescribing errors. The addition of clinical pharmacist services in the care of inpatients results in improved care and reduced harm [4, 5] . Systematic reviews have highlighted difficulty with comparing services between studies. Kaboli et al. [6] found that multidisciplinary working, consultations with patients, medicines reconciliation and providing patient discharge counselling by pharmacists demonstrated improved outcomes. However there was limited generalisability and comparability between studies. Gallagher et al. [7] in their systematic review also highlighted a lack of comparable outcome data and variations in the level of services. Therefore demonstrating cost-effectiveness of clinical pharmacy services remains challenging.
There has been a tacit understanding over many years that there are several activities common to clinical pharmacy services in the United Kingdom (UK) [8, 9] . The Royal Pharmaceutical Society Professional Standards for Hospital Pharmacy Services [10] and guidance in the UK National Institute for Health and Care Excellence (NICE) Medicines Optimisation Guideline [11] provide the key principles for a clinical pharmacy service. Despite this, it is not clear whether clinical pharmacy services are provided in similar ways, what differences exist, and whether similar amounts of time are allocated to direct patient care between different hospitals and organisations. Recent work has been done in the UK National Health Service to benchmark pharmacy services [12] however minimal clinical pharmacy activities were included.
Aim of the study
The aim of the study was to quantitatively compare key clinical pharmacist ward activities across seven acute NHS hospitals. Objectives were to evaluate the similarities and differences and provide a basis for benchmarking.
Ethics approval
Ethics approval was not necessary as the study constituted service evaluation as defined by the participating organisations.
Methods

Settings and participants
The study took place across seven acute hospitals in three NHS organisations in the Greater London area. In all hospitals, wards were visited every weekday by a clinical pharmacist. During each ward visit, pharmacists reviewed patients and their clinical status, assessed prescriptions to ensure that prescribing was legal, safe, effective, appropriate and economical; ensured that there were sufficient supplies of all medication available; provided information, advice and recommendations to other healthcare professionals; undertook medicines reconciliation; and consulted with patients on their medication as needed. All sites have pharmacy technicians and other pharmacy staff providing and supporting ward-based medicines management services in addition to pharmacists. Activities undertaken by pharmacy technicians and other pharmacy support staff include documenting drug histories, ordering and supplying medication, and assessing the suitability of patient's home medicines for use in the hospital.
Clinical pharmacy service provision varies between sites. Table 1 
Design
Data collection took place over five consecutive weekdays in either July or November 2013. Clinical pharmacists generated standardised paper data collection forms with a pre-specified list of activities. This involved several brainstorming sessions, followed by structured discussions to develop an initial list of activities. This list was subsequently validated by a group of clinical pharmacists to ensure all main activities were included. Following successful pilots, pharmacists in each hospital collected data on the numbers and types of patients on the wards, activities undertaken, and amount of time spent during their ward visits. The number of years of experience of each pharmacist was also recorded. The percentage of pharmacists with less than 3 years' experience was reported, as in the UK, this normally indicates pharmacists who are in the early stages of their practice.
Definitions
A patient encounter was defined as a pharmacist having reviewed a patient's drug chart during their visit to the ward irrespective of whether there was an interaction with the patient. If the pharmacist undertook more than one visit to the ward in a day, and encountered the same patient again, this was recorded as a new patient encounter. A clinical pharmacist intervention was defined as any action that directly results in, or is intended to result in, a change to patient management or therapy. The intervention had to be patient-specific, and included clinical contributions to care such as proactive improvements or changes to therapy as well as reactive activities, such as correcting prescribing or medication administration errors. This is similar to the definition used by others [13, 14] updated to take into account that an intervention by a clinical pharmacist may not always involve a doctor and may not result in a change to the prescription.
A transcription check was defined as a check on an inpatient drug chart which has been rewritten because there is no more space either to add more medications or to record further medication administration. The pharmacist checks that the transcription of information from the original drug chart to the new chart is accurate, with no inadvertent changes.
Data analysis
Data were initially organised with Microsoft Excel 2010. IBM SPSS version 21 was used for statistical analysis. Descriptive data were reported using a denominator of 100 occupied bed days, to one decimal place, as this is a recognised denominator for benchmarking services in the UK and internationally. Chi square tests were used to assess differences in the number of activities reported per 100 occupied bed days between sites. Kruskal-Wallis H was used to test for differences across sites for time spent per patient. Statistical significance was set at \0.05 for all analyses.
The average size of a UK hospital ward is 24 beds [15] . Therefore in addition to calculating actual activity per 100 occupied bed days, the number of each activity performed by a pharmacist during a typical ward visit was calculated, by summing each activity and dividing by 24. The median and inter-quartile range were calculated when there was a single site causing a significant variation in a particular activity. Otherwise, the mean and standard deviation were used.
Results
Inpatient activity and clinical pharmacy resource inputs over the 5-day period are shown in Table 2 . Pharmacists in the seven hospitals had 13,022 inpatient encounters. Total occupied bed days reported was 14,331. The mean percentage of inpatient encounters to occupied bed days was 90.6 % (range per hospital 81.9-97.2 %). Pharmacists spent a total of 2291 h (range per hospital 78-969 h) carrying out inpatient clinical pharmacy activities. The proportions of senior (more than 3 years' experience) and junior pharmacists were similar between sites (Chi square = 8.3, p = 0.21). There was a statistically significant difference in the number of minutes a clinical pharmacist spent with a patient between the sites (independent samples KruskalWallis H = 139.7, p \ 0.0005, 6 d.f.). Post-hoc pairwise comparisons (with Bonferroni adjusted p values) showed that the hospitals were split into two distinct groups. In the first group, hospitals H3 and H7 were similar in the number of minutes a clinical pharmacist spent with a patient (11.4 and 13.6 min respectively). In the second group, the remaining five hospitals, the clinical pharmacists spent a similar amount of time with a patient (range 6.7-10.1 min), which was statistically different to the first group. Figure 1 shows aggregated data, organised under the three quality of care criteria-clinical effectiveness, safety and patient-centredness [16] . Table 3 shows the comparative activity rates per 100 occupied bed days for each site.
A total of 219 items were prescribed by pharmacist independent prescribers, ranging from none at H5 to 66 at H7. In the hospitals where independent pharmacist prescribing did take place, the number of pharmacists prescribing ranged from 1 (H6) to 6 (H4).
Typical activities carried out for every 24 occupied beds are described in Fig. 2 .
Discussion
This study provides evidence on the medicines optimisation activities undertaken by clinical pharmacists and benchmarks activity to build a picture of a typical UK hospital clinical pharmacy service. There are some interesting similarities across all sites which helps us to begin to describe a typical service. This is the first time comparative data has been published, despite the relative maturity of clinical pharmacy in the UK.
There are several aspects of this study which support generalisability. Multiple sites and multiple organisations were included. Over 13,000 patient encounters were reported with nearly 40,000 activities undertaken. Apart from mental health services, the participating sites span the range of UK acute hospitals and clinical specialties. The clinical pharmacy services included also represent the breadth and variation seen across the UK [17] .
There were a number of activities where no statistically significant differences between sites were identified. Therefore this provides standardised data for some clinical pharmacist tasks for a typical UK hospital ward of 24 inpatient beds. Service managers can use this standardised data to compare their clinical pharmacy services and use it as a benchmark for business planning for current services as well as future developments. It will also allow providers to assure themselves of the effectiveness, safety and patient-centeredness of their clinical pharmacy services. However, it is important to compare data with similar hospitals.
Variations in several activities do exist between the sites, some of which may be explained by differences in hospital services and specialties, and the use of ward information technology (IT) systems. The proportions of junior and senior staff were however, similar.
Site H7 has implemented electronic prescribing and medication administration (ePMA) and has electronic patient records. This has influenced the way the clinical pharmacy service is delivered as described by Donyai et al. [18] , as well as leading to changes in the pharmacy ward activity profile. Transcription checks of drug charts are not required; electronic patient records are easier to access and facilitate the documentation of information; fewer medications are endorsed for clarity and safety as such information can be prepopulated; and illegible handwriting is no longer a problem. A key role for pharmacists is to optimise medication therapy by intervening on patient care as appropriate. H7 had the highest number of clinical pharmacy interventions per 100 occupied beds. This could reflect the greater clinical time spent for each patient, the larger number of patients records accessed and/or the number of blood results checked. Site H5 recorded the least number of interventions, and also checked blood results and accessed patient records the least. However, this site is the least acute, meaning patients will have less complex medication regimens, fewer pharmaceutical issues and require less monitoring.
H5 and H6 have a dedicated pharmacy led therapeutic drug monitoring service. This service receives referrals from all healthcare professionals, including ward pharmacists, for advice and pharmacokinetic calculations to aid dosing and monitoring for patients prescribed medication with a narrow therapeutic index. The presence of this service could account for ward pharmacists in these two hospitals performing fewer calculations. Pharmacists at H4 performed the greatest number of calculations. Although this hospital has a large neonatal and paediatric bed base, requiring more complex calculations, the large variation compared to other sites means that this is unlikely to be the only driver. Site H2 had a statistically significant greater number of medications endorsed for clarity and/or safety. This could be due to the fact that this hospital has a high percentage of specialist beds and therefore drug charts may require additional endorsements by pharmacists due to the complexity of the patients. However, it is not clear if this is the true explanation for the difference.
Pharmacists in H5 completed the supply of medications for fewer discharge prescriptions on wards compared to the other sites. This is the smallest hospital in the study, and has a centrally located pharmacy, providing staff easy access to the dispensary. In this hospital it is quicker, safer and more efficient to supply medications direct from the dispensary, therefore the pharmacy department do not actively encourage the supply of discharge medication from wards.
Pharmacists had to clarify 54 % of discharge prescriptions written by doctors. This proportion is mirrored in other studies [19] . Interestingly, this was not significantly different in H7, where doctors wrote a minority of the discharge medication prescriptions (in this hospital, pharmacists write most discharge prescriptions). This may indicate that pharmacists writing discharge medication lists does not affect doctors' skills in carrying out this task. PaƟent records were checked for informaƟon 5,809 Ɵmes and blood results were checked 6,312
Ɵmes.
2,348 calculaƟons were performed.
Pharmacists in H2, H4, H5 and H6 recorded the number of Ɵmes they made an entry in the paƟent record. 754 entries were logged, ranging from 9 in H5 to 570 (76% of the total) in H2.
Pharmacists independent prescribers prescribed SAFETY 3,717 new paƟents reviewed. 2,700 medicaƟon histories documented.
A drug allergy or intolerance status was confirmed or clarified 2,895 Ɵmes.
548 rewriƩen or transcribed charts checked for accuracy.
5,901 individual medicaƟon orders were annotated for clarity or safety.
1,087 discharge prescripƟons wriƩen by doctors were checked for clinical appropriateness and safety, of which 54% (range 46% -63%) needed one or more correcƟons.
PATIENT-CENTREDNESS
792 paƟent consultaƟons.
5,380 medicaƟons were ordered for inpaƟent use, either for individual paƟents or as ward stock.
32% (range 17 -38%) of discharge prescripƟons had all medicaƟons available for supply direct from the ward.
496 discharge medicaƟon lists were wriƩen by pharmacists at two sites, to improve discharge for paƟents.
Fig. 1 Total activities reported by clinical pharmacists
It is generally accepted that all inpatients should receive a consultation about their medication at some point during the admission, however there was a surprisingly low number of patient consultations. Overall, the ratio of patient consultations to patient encounters was 6 %, much lower than expected. Patient consultations form part of the KPIs at H5, which may explain the relatively high ratio at that site. However this study did not measure the quality of information provided to the patients. There is an opportunity for future work to improve this aspect of patient care.
There was limited pharmacist independent prescribing for inpatients. Service leads should look at expanding the use of this resource to improve patient care [20, 21] as pharmacist independent prescribers have been shown to provide a valuable role in prescribing safely for hospital inpatients [22] .
There are some limitations to this study. Activity data from clinical pharmacy technicians and other pharmacy support staff working on wards were not included.
Incorporating this data in future work may give a more detailed picture of the activity undertaken by the full clinical pharmacy team, subsequently allowing a discussion on skill mix. The data was self-reported therefore unknown biases are possible. It is possible that not all activities were recorded. All the hospitals are located in or around London, thus may not be typical of the rest of the UK. It was not possible to collect data on all ward-based activities, such as antimicrobial stewardship or multi-disciplinary ward round attendance. The study does not assess patient outcomes or experience, however pharmacy-sensitive outcomes are yet to be agreed. Additionally, clinical pharmacy practice in the UK is rapidly changing, as more potential roles for clinical pharmacy staff are identified. It should be recognised that this study represents a snapshot, taken at a particular moment in time.
Future work should repeat this benchmarking exercise, as UK clinical pharmacy practice is evolving, with the current drive to implement 7-day working, improve a Site contributing the greatest variation to that activity efficiency and reduce variation between NHS hospital pharmacy services [23] .
Conclusion
This study provides the first detailed comparison of clinical pharmacy activities in a range of different UK hospitals.
We have identified the average number of activities and time spent on a ward by a pharmacist, to allow services to be benchmarked. Service managers in each NHS organisation involved have utilised this data to review the clinical pharmacist service, to identify areas of strength and areas for improvement.
